Learn more

PFIZER RES & DEV

Overview
  • Total Patents
    643
About

PFIZER RES & DEV has a total of 643 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Israel, Canada and South Africa. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are VERNALIS OXFORD LTD, ACETYLON PHARMACEUTICALS and IYAKU BUNSHI SEKKEI KENKYUSHO.

Patent filings per year

Chart showing PFIZER RES & DEVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mackenzie Alexander Roderick 72
#2 Dunn Peter James 60
#3 Fray Michael Jonathan 48
#4 Wythes Martin James 40
#5 Macrae Ross James 38
#6 Mowbray Charles Eric 35
#7 Stobie Alan 34
#8 Meadows Sandra Dora 31
#9 Wood Albert Shaw 31
#10 Middleton Donald Stuart 30

Latest patents

Publication Filing date Title
TW577756B Controlled-release pharmaceutical formulations
AU4340799A Use of indole derivatives for the treatment of various diseases
AU3688499A Pharmaceutical formulations containing darifenacin
CN1240134A Nose added medicinal preparation for curing sexual function disturbance
TW542719B Method of treating impotence due to spinal cord injury
IL122653D0 Benzopyrans and their preparation
TW391961B Process for preparing sildenafil
CN1207096A 3-azetidinylalkylpiperidines or-pyrrolidines as tachykinin antagonists
CN1205693A Quinoline and quinazoline compounds useful in therapy
CN1189162A Triazole anti-fungal agents
CA2203379A1 Cgmp-pde inhibitors for the treatment of erectile dysfunction
CA2213241A1 Indole derivative for the treatment of migraine
CA2202348A1 Indole derivatives as 5ht1-like agonists
TW390880B Anti-migraine compound and pharmaceutical composition and process for preparating the same
TW432061B Lactams
BR9502663A Alpha gamma and crystalline polymorphic delta form of a compound compound Pharmaceutical composition use process of treating an animal process for the preparation of an alpha polymorphic crystalline and amorphous beta form of a compound
BR9501945A Compound process pharmaceutical compositions use and process for treating mammals
BR9500661A Compound pharmaceutical composition use process to inhibit 5-alpha-reductase-1, process for treatment or prophylaxis of pattern baldness processes to obtain a compound of a composition
BR9500437A Compound pharmaceutical composition use process of treating a human being processes for preparing a pharmaceutical composition
IL128835A Intermediates for the preparation of crystalline, polymorphic (sss) -n- (1-[2-carboxy-3-(n<2>-mesyllysylamino)propyl]-1-cyclopentylcarbonyl) tyrosine